D
DNLI//CIK 0001714899
Denali Therapeutics Inc.
Market Data
$21.09−$3.60 (−14.58%)
DNLI · Last trade
Prev Close
$24.69
Range (30d)
$21.09 – $25.69
Recent Filings
- 1444.8 KBDenali Therapeutics Inc.Sep 4, 8:38 PM ET·0002124755-26-000006
- 1445.0 KBDenali Therapeutics Inc.Sep 2, 4:31 PM ET·0001950047-26-009017
- 1444.8 KBDenali Therapeutics Inc.Sep 1, 4:47 PM ET·0001950047-26-008944
- 1444.8 KBDenali Therapeutics Inc.Aug 11, 5:39 PM ET·0001724311-26-000012
- 10-Q6.8 MBDenali Therapeutics Inc.Aug 6, 4:08 PM ET·0001714899-26-000097
- 8-K325.9 KBDenali Therapeutics Inc.Aug 6, 4:03 PM ET·0001714899-26-000096
- SCHEDULE 13G/A7.7 KBDenali Therapeutics Inc.Aug 4, 9:11 AM ET·0001088875-26-000056
- 8-K161.8 KBDenali Therapeutics Inc.Jul 27, 9:01 PM ET·0001714899-26-000086
- 8-K221.7 KBDenali Therapeutics Inc.Jun 18, 8:01 AM ET·0001714899-26-000081
- 8-K244.7 KBDenali Therapeutics Inc.May 21, 6:17 PM ET·0001714899-26-000070
Insiders
10- 667, L.P.Director
- AFEYAN NOUBAR10% Owner
- ARCH Venture Fund VIII, L.P.10% Owner
- ARCH Venture Partners VIII, LLC10% Owner
- ARCH Venture Partners VIII, L.P.10% Owner
- Baker Bros. Advisors (GP) LLCDirector
- BAKER BROS. ADVISORS LPDirector
- Baker Brothers Life Sciences LPDirector
- BAKER FELIXDirector
- BAKER JULIANDirector
Tickers
Addresses
business
161 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO, CA, 94080
mailing
161 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO, CA, 94080